Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cipher Gene Tech

Explore full profile

Cipher Gene Tech is a bio medical big data analysis and interpretation platform

Dongcheng District, ChinaFounded 2015Biotech & Life Sciences
Valuation $50–100M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Cipher Gene Tech and the history behind them.

About Cipher Gene Tech

Established in October 2015, Cipher Gene Tech operates at the intersection of genomics and artificial intelligence, positioning itself as a precision medicine service provider. The company, with headquarters in Beijing, China, and Lewes, Delaware, in the US, focuses on developing an automated platform for the analysis and interpretation of genetic data. Its primary market consists of third-party research institutes, universities, and hospitals. Cipher Gene Tech generates revenue by providing high-quality data analysis, support services, and genetic testing products related to inherited diseases and cancer to these institutions.

The core of the company's offering is an intelligent platform designed to automate and visualize the interpretation of complex genetic data, aiming to enhance the accuracy of clinical diagnoses. This service is particularly focused on the field of childhood genetic diseases, where it assists physicians in making more efficient and precise treatment decisions. The business model hinges on collaboration; by working closely with clinical doctors and research organizations, Cipher Gene continually refines its algorithms and workflows. The company has successfully navigated multiple funding rounds, including a seed round in February 2016 and a Series C round in May 2024, accumulating total funding of over $30 million.

Cipher Gene Tech's platform is supported by a multidisciplinary team with expertise in bioinformatics, molecular biology, genetics, and statistics. This integrated team is responsible for testing, optimizing, and integrating the various algorithms and protocols necessary for analyzing different types of genetic data. The company operates within the Laboratory Services (Healthcare) industry, with a vertical focus on Artificial Intelligence & Machine Learning, Life Sciences, and Oncology. Investors include entities such as Jinjiang Development, Tsinghua Innovation Ventures, and TusStar Incubator, reflecting confidence in its specialized market approach.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Dongcheng District, China
Employees
9
Open positions
None listed
Dealroom signal
55.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Developer Tools, Biotechnology, Hard Tech, DT and LS, science-based
Technology
Big Data, Deep Tech
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC May 2024 $14M $55M Jinjiang Development Group · Zhongxi Fund ↗
SERIES BEquity / VC Jul 2020 — — CS Capital ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Cipher Gene Tech website traffic

Latest recorded traffic for Cipher Gene Tech is 980 monthly website visits, up 444.4% over the last three months. Cipher Gene Tech's team grew 0% over the past year.

Latest monthly visits980 3-month web change+444.4% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Shenzhen Guozhong Venture Capital Management
  • CS Capital

Series B and later2 investors entered at this stage

  • Jinjiang Development Group
  • Zhongxi Fund
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China60%
🇺🇸 United States40%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cipher Gene Tech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cipher Gene Tech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.